Financial Gravity Asset Management’s Acorda Therapeutics ACOR Stock Holding History

Financial Gravity Asset Management’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Hold	0	–	–	–	1769
2019 Q3	–	Hold	0	–	–	–	1625
2019 Q2	–	Sell	-28	Closed	-$34.4K	–	1752
2019 Q1	$44K	Buy	+28	New	+$50.4K	0.04%	344
2018 Q3	$48K	Buy	+22	New	+$68.1K	0.05%	338
2018 Q2	–	Hold	0	–	–	–	1312

Other funds holding ACOR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Financial Gravity Asset Management's ACOR Position: Q4 2019 in Review

Financial Gravity Asset Management held its Acorda Therapeutics (ACOR) position steady in Q4 2019 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1769.

Financial Gravity Asset Management first reported a position in ACOR in Q3 2018 and has held it in 2 quarters since. The position peaked at $48K in Q3 2018. 121 funds tracked by Wall St. Rank hold ACOR as of Q4 2019.

Financial Gravity Asset Management held 0 shares of Acorda Therapeutics worth $0 as of Q4 2019.
Financial Gravity Asset Management left its Acorda Therapeutics share count unchanged in Q4 2019.
Acorda Therapeutics made up ﹤0.01% of Financial Gravity Asset Management's portfolio in Q4 2019, its #1769 holding.
Financial Gravity Asset Management first reported a position in Acorda Therapeutics in Q3 2018 and has held it in 2 quarters since.
Financial Gravity Asset Management's Acorda Therapeutics position peaked at $48K in Q3 2018.
121 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2019.

Based on Financial Gravity Asset Management's 13F filing for Q4 2019, filed 28 Feb 2020.